alpha-naphthoflavone has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukumoto, S; Harama, D; Ikegami, S; Ishimaru, K; Kitamura, M; Makino, S; Nakamura, Y; Nakao, A; Shimokawa, N; Takamura, T | 1 |
1 other study(ies) available for alpha-naphthoflavone and Colitis Gravis
Article | Year |
---|---|
Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis.
Topics: Animals; Benzoflavones; Cell Line, Tumor; Colitis, Ulcerative; Colon; Cytochrome P-450 CYP1A1; Dextran Sulfate; Female; Humans; Lactobacillus; Mice; Mice, Inbred C57BL; Probiotics; Receptors, Aryl Hydrocarbon; RNA, Messenger; Signal Transduction | 2011 |